Friday, May 9, 2014

Ulcerative Colitis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Transparency Market Research Reports included a detailed market survey and analysis trends on “Ulcerative Colitis Therapeutics Market”. This report also includes more info about basic overview of the industry including definitions, applications and global market industry structure.

Ulcerative colitis is a chronic idiopathic inflammatory bowel disease (IBD) of the gastrointestinal tract that affects the mucosal lining of the colon commonly occur in people aged between 15-30 years. Ulcerative colitis is one of the 2 major types of IBD along with Crohn’s disease. Unlike Crohn’s disease, which can affect any part of the gastrointestinal tract, ulcerative colitis characteristically involves only the large bowel. The actual cause of the disease is still unidentified but with the available information it may be the result of an over reactive immune response to normal bacteria and other substances in the gastrointestinal tract.

The prominent symptoms of ulcerative colitis are abdominal pain and bloody diarrhea due to inflammation and the development of open sores (ulcers) in the large intestine (colon) and rectum. Other symptoms of ulcerative colitis include abdominal cramping, nausea, fever, skin ulcers, loss of appetite, weight loss, joint pain, and fatigue. Severe complications of ulcerative colitis include hemorrhage, colon rupture, and the possible development of colon cancer. About 20% of people with ulcerative colitis have a family member with the disease or with Crohn's disease which is also a type of IBD. There is no known cure for ulcerative colitis till now, but therapies are available that may significantly reduce the signs and symptoms of ulcerative colitis and even bring about a long-term remission.

Therapeutics market for ulcerative colitis can be segmented based upon drug classes:
  • Aminosalicylates
    • Sulfasalazine
    • Mesalamine
    • Balsalazide
  • Corticosteroids
    • Prednisone
    • Methylprednisolone
  • Immunomodulators
    • ulcerative colitis
  • Antibiotics
    • Ampicillin
    • Ciprofloxacin
  • Other
The prevalence of ulcerative colitis varies with the geographical location. According to the U.S. Pharmacist Northern Europe, United Kingdom and North America have highest reported disease incidences in past few years. The disease in U.S. approximately affects 250,000 to 500,000 people annually. Although there are few epidemiologic data from developing countries, the incidence and prevalence of IBD are growing with time and in different regions around the world, indicating its occurrence as a global disease. 

Recent FDA approved drugs include SIMPONI ARIA as an infusion treatment from Janssen Biotech, Inc., in July 2013, UCERIS from Santarus Inc., in Jan 2013, DELZICOL from Warner Chilcott in April 2013, among others. Some of the leading drug manufacturer for Ulcerative colitis includes Johnson & Johnson, Abbott Laboratories, Takeda Pharmaceutical Company, Pfizer Inc., Janssen Biotech, Inc. among other.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
·         It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

About Us:-
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030

Browse Market Researche Report:-


Post a Comment